THEY SAID IT! U.S. House Ways & Means Subcommittee Pushes For Increased Competition To Lower Drug Prices
On Thursday, members of the U.S. House Committee on Ways and Means… Read More
On Thursday, members of the U.S. House Committee on Ways and Means… Read More
Patients Tell Congress, Paying For Life-Saving Medications Often Means Going… Read More
On Wednesday, five American patients gave eye-opening testimony to members of… Read More
Big Pharma is able to price gouge patients and avoid accountability. For… Read More
FDA Commissioner Was Invaluable Voice In Favor Of Market-Based Solutions To… Read More
Three More Hearings Will Keep Attention On The Impact Of Big Pharma’s… Read More
Testimony from Seven Drug Makers Showcases Continued Unwillingness to Take… Read More
On Tuesday, the U.S. Senate Committee on Finance held its second hearing on… Read More
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released… Read More
Big Pharma’s True Track Record Is A Hard Pill To Swallow Looking back at Big… Read More
In advance of the U.S. Senate Committee on Finance hearing on February 26,… Read More
By Sarah Gleich Saturday, Feb. 23, 2019 I have had diabetes since I was 5… Read More